Align Technology (ALGN) Stock Forecast: What Could Drive It in 2026
Last updated July 2026
Short answer
What is actually driving Align Technology (ALGN) right now is Clear-aligner market penetration: Clear aligners still represent a minority of the roughly 500 million people worldwide with malocclusion, leaving a long runway as treatment shifts away from metal braces. Revenue (FY2025) is ~$4.0B. If that keeps playing out, the setup is favourable; the risk to it is growth has decelerated to low single digits as the North American clear-aligner market matures and consumers pull back on discretionary, often out-of-pocket dental spending during economic softness. No one can predict where ALGN trades, and Walnut does not publish targets, so treat this as a scenario, not a price target or prediction.
What could drive Align Technology (ALGN) higher?
1. Clear-aligner market penetration
Clear aligners still represent a minority of the roughly 500 million people worldwide with malocclusion, leaving a long runway as treatment shifts away from metal braces. Align's brand, doctor relationships, and case-management software position it to capture a meaningful share of that expansion. Growth in EMEA, APAC, and Latin America has been running at double-digit rates, offsetting a more mature North America.
2. iTero scanner and digital ecosystem
The iTero scanner line and exocad CAD/CAM software lock doctors into Align's digital workflow, with the majority of Invisalign cases now submitted through digital scans. This razor-and-blade dynamic drives recurring aligner volume and switching costs. New scanner models and AI-assisted treatment tools aim to deepen that ecosystem advantage.
3. Margin profile and capital returns
Align operates with gross margins near 70 percent and generates substantial free cash flow, which it has been directing toward share repurchases, including a fresh $200 million authorization announced in early 2026. Manufacturing scale in lower-cost regions supports profitability. Disciplined cost management gives the company flexibility to invest in growth while returning cash.
4. Adult and teen segment expansion
Align continues to broaden its addressable base, with growth in adult patients seeking discreet treatment and in teens and younger patients where clear aligners are displacing braces. Product features aimed at complex cases expand the range of treatments aligners can address. Direct-to-consumer marketing and doctor-education programs support demand across both cohorts.
What could weigh on ALGN?
Growth has decelerated to low single digits as the North American clear-aligner market matures and consumers pull back on discretionary, often out-of-pocket dental spending during economic softness. Competition is intensifying from lower-priced systems such as Straumann's ClearCorrect, Dentsply Sirona's SureSmile, and Envista's Spark, which can pressure both volume and pricing. Align manufactures aligners in Mexico and ships them to the United States, exposing it to tariff and trade-policy shifts, and a large portion of revenue is international, adding foreign-exchange sensitivity. The premium valuation leaves little room for disappointment, so a growth stumble can drive an outsized share reaction. Patent expirations over time may further lower barriers to entry for competitors.
Where ALGN trades today
A forecast starts from where the stock actually is. These are ALGN's current figures, not a projection: the drivers and risks above are what would move them.
Snapshot for ALGN as of July 2026, sourced from Yahoo Finance and may be delayed. Valuation figures move with price and earnings; verify the current numbers with your broker before deciding.
How to think about a ALGN forecast
Rather than chasing a price target, it tends to help to weigh the drivers above against the risks, decide how long you are willing to hold, and size the position so a wrong call is survivable. A “forecast” is really a probability-weighted view of those drivers playing out, not a number.
For the full picture, see the ALGN guide and whether ALGN is a buy. In Walnut you can pressure-test the thesis against your real portfolio.
The bottom line on the ALGN outlook
The bottom line: what is driving Align Technology (ALGN) is Clear-aligner market penetration, with revenue (fy2025) at ~$4.0B. If that keeps playing out the setup is favourable; the risk is growth has decelerated to low single digits as the North American clear-aligner market matures and consumers pull back on discretionary, often out-of-pocket dental spending during economic softness. No one can predict the price, so treat any ALGN forecast as a scenario, not a target or prediction, and decide from your own thesis and time horizon. Walnut is not an investment adviser.
Build a basket around ALGN with Walnut
Use Align Technology as one constituent in a thematic basket Walnut's AI helps you assemble. Describe a thesis you believe in, the AI proposes the holdings and weights, and you approve before any broker order.
FAQ
What is the forecast for Align Technology (ALGN)?
+
No one can reliably predict where ALGN will trade, and Walnut does not publish price targets. What is more useful is the setup: the drivers that could push Align Technology higher and the risks that could weigh on it. This page lays out both so you can form your own view. Not a recommendation.
What could drive ALGN higher?
+
The main growth drivers are Clear-aligner market penetration; iTero scanner and digital ecosystem; Margin profile and capital returns. Whether they play out is the real question, not a guaranteed path.
What are the risks to ALGN?
+
Growth has decelerated to low single digits as the North American clear-aligner market matures and consumers pull back on discretionary, often out-of-pocket dental spending during economic softness. Competition is intensifying from lower-priced systems such as Straumann's ClearCorrect, Dentsply Sirona's SureSmile, and Envista's Spark, which can pressure both volume and pricing. Align manufactures aligners in Mexico and ships them to the United States, exposing it to tariff and trade-policy shifts, and a large portion of revenue is international, adding foreign-exchange sensitivity. The premium valuation leaves little room for disappointment, so a growth stumble can drive an outsized share reaction. Patent expirations over time may further lower barriers to entry for competitors.
Will ALGN stock go up in 2026?
+
Nobody knows, and anyone who says they do is guessing. Align Technology's direction depends on whether the drivers above outweigh the risks, plus the broader market. Focus on the thesis and your time horizon rather than a single-year call.
Is ALGN a buy?
+
That depends on your thesis, time horizon, and what you already own, not on a forecast. See the ALGN "is it a buy?" page for a framework. Walnut is not an investment adviser.
Why has Align's revenue growth slowed?
+
Growth cooled to low single digits as the North American clear-aligner market matured, consumers grew cautious about discretionary dental spending, and lower-priced competitors expanded. International regions such as EMEA, APAC, and Latin America have been growing faster and partly offsetting the slowdown.
Walnut is informational, not investment advice. This page describes drivers and risks; it is not a price forecast, target, or recommendation. Markets are uncertain and past performance does not predict future results.